Get the Stockscreener App
2.28
2.70%
0.06
Inmed Pharmaceuticals Inc stock is traded at $2.28, with a volume of 29,428.
It is up +2.70% in the last 24 hours and down -13.96% over the past month.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
See More
Previous Close:
$2.22
Open:
$2.26
24h Volume:
29,428
Relative Volume:
0.01
Market Cap:
$4.56M
Revenue:
$4.96M
Net Income/Loss:
$-6.82M
P/E Ratio:
-0.0349
EPS:
-65.4
Net Cash Flow:
$-6.64M
1W Performance:
-1.72%
1M Performance:
-13.96%
6M Performance:
-26.92%
1Y Performance:
-72.30%
1-Day Range:
$2.23
$2.2965
1-Week Range:
$2.15
$2.33
52-Week Range:
$1.72
$9.376
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Name
Inmed Pharmaceuticals Inc
Sector
Phone
(604) 669-7207
Address
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
2.28 | 4.61M | 4.96M | -6.82M | -6.64M | -65.40 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Inmed Pharmaceuticals Inc Stock (INM) Latest News
InMed Pharmaceuticals Inc. stock trend forecast2025 Price Targets & Risk Controlled Daily Plans - Newser
Should you hold or exit InMed Pharmaceuticals Inc. nowWeekly Investment Recap & Community Supported Trade Ideas - Newser
How to monitor InMed Pharmaceuticals Inc. with trend dashboardsJuly 2025 Retail & Safe Capital Preservation Plans - Newser
InMed Pharmaceuticals Inc. stock trend outlook and recovery path2025 Valuation Update & AI Based Buy and Sell Signals - Newser
Can trapped investors hope for a rebound in InMed Pharmaceuticals Inc.Portfolio Performance Summary & Weekly Market Pulse Alerts - Newser
How to interpret RSI for InMed Pharmaceuticals Inc. stockEarnings Risk Report & Safe Entry Zone Identification - Newser
Multi asset correlation models including InMed Pharmaceuticals Inc.Quarterly Market Review & Real-Time Sentiment Analysis - Newser
What to do if you’re stuck in InMed Pharmaceuticals Inc.2025 Market Outlook & Verified Short-Term Trading Plans - Newser
Can trapped investors hope for a rebound in InMed Pharmaceuticals IncJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
Identifying reversal signals in InMed Pharmaceuticals Inc.2025 Winners & Losers & Low Risk Entry Point Guides - Newser
What MACD and RSI say about InMed Pharmaceuticals Inc.Earnings Overview Report & Safe Investment Capital Preservation Plans - Newser
Using R and stats models for InMed Pharmaceuticals Inc. forecastingDollar Strength & Low Risk Investment Opportunities - Newser
Published on: 2025-08-18 03:37:19 - Newser
Why InMed Pharmaceuticals Inc. stock is on top investor watchlistsAnalyst Downgrade & Pattern Based Trade Signal System - Newser
Custom strategy builders for tracking InMed Pharmaceuticals Inc.2025 Market Overview & Low Drawdown Momentum Ideas - Newser
Published on: 2025-08-17 06:24:14 - Newser
Published on: 2025-08-16 06:14:12 - Newser
Published on: 2025-08-16 03:30:14 - Newser
Exit strategy if you’re trapped in InMed Pharmaceuticals Inc.2025 EndofYear Setup & Technical Pattern Based Signals - Newser
News impact scoring models applied to InMed Pharmaceuticals Inc.Trend Reversal & High Conviction Trade Alerts - Newser
What makes InMed Pharmaceuticals Inc. stock price move sharplyJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - Newser
Quantitative breakdown of InMed Pharmaceuticals Inc. recent moveWeekly Investment Recap & Technical Analysis for Trade Confirmation - Newser
InMed Pharmaceuticals Inc. Stock Flags Risk Zone in Volatility IndexWatchlist for Low Risk High Return Stocks Updated - sundaytimes.kr
Using RSI to spot recovery in InMed Pharmaceuticals Inc.Free Real Market Momentum Signal Generator - Newser
Glaucoma Pipeline 2025: MOA and ROA Insights, Clinical Trials - openPR.com
What MACD and RSI say about InMed Pharmaceuticals IncFree Capital Protection Trading Strategies - Newser
Glaucoma Pipeline 2025: MOA And ROA Insights, Clinical Trials Status, And Key Companies Involved By Delveinsight Q Biomed, Inmed Pharma, ONL Therapeutics, Mitotech, Theratocular Biotek - Menafn
InMed Pharmaceuticals Inc. stock outlook for YEARFundamental Forecast for Undervalued Stocks - Newser
Published on: 2025-08-10 20:48:17 - Newser
Inmed Pharmaceuticals Inc Stock (INM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):